Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

ClinicalTrials.gov ID: NCT01179048

Public ClinicalTrials.gov record NCT01179048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 1:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.

Study identification

NCT ID
NCT01179048
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
9,341 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2010
Primary completion
Dec 16, 2015
Completion
Dec 16, 2015
Last update posted
Jul 16, 2019

2010 – 2015

United States locations

U.S. sites
125
U.S. states
33
U.S. cities
109
Facility City State ZIP Site status
Novo Nordisk Investigational Site Alabaster Alabama 35007 —
Novo Nordisk Investigational Site Birmingham Alabama 35209 —
Novo Nordisk Investigational Site Birmingham Alabama 35294 —
Novo Nordisk Investigational Site Huntsville Alabama 35801 —
Novo Nordisk Investigational Site Mobile Alabama 36608 —
Novo Nordisk Investigational Site Tempe Arizona 85283 —
Novo Nordisk Investigational Site Little Rock Arkansas 72205-5446 —
Novo Nordisk Investigational Site Little Rock Arkansas 72205 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Cerritos California 90703-2115 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93721-1443 —
Novo Nordisk Investigational Site Los Angeles California 90017-4006 —
Novo Nordisk Investigational Site Los Banos California 93635 —
Novo Nordisk Investigational Site Mission Hills California 91345 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Watsonville California 95076 —
Novo Nordisk Investigational Site Aurora Colorado 80045-7402 —
Novo Nordisk Investigational Site Denver Colorado 80220 —
Novo Nordisk Investigational Site Newark Delaware 19713 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Clearwater Florida 33756 —
Novo Nordisk Investigational Site DeLand Florida 32724 —
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316 —
Novo Nordisk Investigational Site Kissimmee Florida 34744 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Orlando Florida 32804 —
Novo Nordisk Investigational Site St. Petersburg Florida 33711 —
Novo Nordisk Investigational Site Tampa Florida 33624 —
Novo Nordisk Investigational Site West Palm Beach Florida 33409 —
Novo Nordisk Investigational Site Lawrenceville Georgia 30046 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Chicago Illinois 60612 —
Novo Nordisk Investigational Site Chicago Illinois 60654 —
Novo Nordisk Investigational Site Crystal Lake Illinois 60012 —
Novo Nordisk Investigational Site Indianapolis Indiana 46260-1992 —
Novo Nordisk Investigational Site Michigan City Indiana 46360 —
Novo Nordisk Investigational Site West Des Moines Iowa 50265 —
Novo Nordisk Investigational Site Lexington Kentucky 40502 —
Novo Nordisk Investigational Site Louisville Kentucky 40202 —
Novo Nordisk Investigational Site Louisville Kentucky 40206 —
Novo Nordisk Investigational Site Metairie Louisiana 70006-2930 —
Novo Nordisk Investigational Site Monroe Louisiana 71203 —
Novo Nordisk Investigational Site Natchitoches Louisiana 71457-5881 —
Novo Nordisk Investigational Site New Orleans Louisiana 70112 —
Novo Nordisk Investigational Site Baltimore Maryland 21204 —
Novo Nordisk Investigational Site Baltimore Maryland 21218-2829 —
Novo Nordisk Investigational Site Bloomfield Hills Michigan 48302 —
Novo Nordisk Investigational Site Dearborn Michigan 48124 —
Novo Nordisk Investigational Site Interlochen Michigan 49643 —
Novo Nordisk Investigational Site Troy Michigan 48085-5524 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55416 —
Novo Nordisk Investigational Site Springfield Missouri 65807 —
Novo Nordisk Investigational Site St Louis Missouri 63108 —
Novo Nordisk Investigational Site Great Falls Montana 59405 —
Novo Nordisk Investigational Site Omaha Nebraska 68105 —
Novo Nordisk Investigational Site Lebanon New Hampshire 03756 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Mine Hill New Jersey 07803 —
Novo Nordisk Investigational Site Neptune City New Jersey 07753-4859 —
Novo Nordisk Investigational Site Albany New York 12208 —
Novo Nordisk Investigational Site Buffalo New York 14221-7091 —
Novo Nordisk Investigational Site New York New York 10032 —
Novo Nordisk Investigational Site New York New York 10036 —
Novo Nordisk Investigational Site New York New York 10065 —
Novo Nordisk Investigational Site Smithtown New York 11787 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site Westfield New York 14787 —
Novo Nordisk Investigational Site Asheville North Carolina 28801 —
Novo Nordisk Investigational Site Burlington North Carolina 27215 —
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517 —
Novo Nordisk Investigational Site Greensboro North Carolina 27401 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Monroe North Carolina 28110 —
Novo Nordisk Investigational Site Mooresville North Carolina 28117 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Whiteville North Carolina 28472 —
Novo Nordisk Investigational Site Cadiz Ohio 43907 —
Novo Nordisk Investigational Site Cincinnati Ohio 45219 —
Novo Nordisk Investigational Site Cincinnati Ohio 45220-2213 —
Novo Nordisk Investigational Site Cleveland Ohio 44106 —
Novo Nordisk Investigational Site Marion Ohio 43302 —
Novo Nordisk Investigational Site Middleburg Heights Ohio 44310 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009-1957 —
Novo Nordisk Investigational Site Hatfield Pennsylvania 19440 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15243 —
Novo Nordisk Investigational Site Uniontown Pennsylvania 15401 —
Novo Nordisk Investigational Site Charleston South Carolina 29455 —
Novo Nordisk Investigational Site Columbia South Carolina 29203 —
Novo Nordisk Investigational Site Greenville South Carolina 29607 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576 —
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572 —
Novo Nordisk Investigational Site Bartlett Tennessee 38133 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Memphis Tennessee 38163 —
Novo Nordisk Investigational Site Nashville Tennessee 37212 —
Novo Nordisk Investigational Site Arlington Texas 76014 —
Novo Nordisk Investigational Site Corpus Christi Texas 78404 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75390 —
Novo Nordisk Investigational Site Houston Texas 77070 —
Novo Nordisk Investigational Site Houston Texas 77095 —
Novo Nordisk Investigational Site Longview Texas 75605 —
Novo Nordisk Investigational Site Lubbock Texas 79423 —
Novo Nordisk Investigational Site Odessa Texas 79761 —
Novo Nordisk Investigational Site San Antonio Texas 78228-3419 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Schertz Texas 78154 —
Novo Nordisk Investigational Site Tomball Texas 77375 —
Novo Nordisk Investigational Site Salt Lake City Utah 84102 —
Novo Nordisk Investigational Site South Burlington Vermont 05403 —
Novo Nordisk Investigational Site Spokane Washington 99210 —
Novo Nordisk Investigational Site Madison Wisconsin 53717 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 303 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01179048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2019 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01179048 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →